APA

Kraaij T., Kamerling S. W. A., de Rooij E. N. M., van Daele P. L. A., Bredewold O. W., Bakker J. A., Bajema I. M., Scherer H. U., Toes R. E. M., Huizinga T. J. W., Rabelink T. J., van Kooten C. & Teng Y. K. O. (20190408). The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. : Journal of autoimmunity.

Chicago

Kraaij Tineke, Kamerling Sylvia W A, de Rooij Esther N M, van Daele Paul L A, Bredewold Obbo W, Bakker Jaap A, Bajema Ingeborg M, Scherer Hans U, Toes Rene E M, Huizinga Tom J W, Rabelink Ton J, van Kooten Cees and Teng Y K Onno. 20190408. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. : Journal of autoimmunity.

Harvard

Kraaij T., Kamerling S. W. A., de Rooij E. N. M., van Daele P. L. A., Bredewold O. W., Bakker J. A., Bajema I. M., Scherer H. U., Toes R. E. M., Huizinga T. J. W., Rabelink T. J., van Kooten C. and Teng Y. K. O. (20190408). The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. : Journal of autoimmunity.

MLA

Kraaij Tineke, Kamerling Sylvia W A, de Rooij Esther N M, van Daele Paul L A, Bredewold Obbo W, Bakker Jaap A, Bajema Ingeborg M, Scherer Hans U, Toes Rene E M, Huizinga Tom J W, Rabelink Ton J, van Kooten Cees and Teng Y K Onno. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. : Journal of autoimmunity. 20190408.